Medtech Insights

The Asia Pacific market for PV devices will grow modestly through 2029, fueled by the growing PAD population and the adoption of premium devices like DCBs, DES, and powered thrombectomy…

The European market for PV devices is a dynamic market that will grow steadily through 2029, driven by the availability of new products backed by clinical data. However, market revenues will be…

The European market for PV devices continues to expand, driven primarily by procedure volume growth in the lower-limb indications and adoption of premium-priced products. This Medtech 360…

The European market for PV devices is a dynamic market that will grow through 2029, driven by the availability of new products backed by clinical data. However, market revenues will be hindered…

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for moderate expansion through 2029, despite the…

The Japanese PV device market will see modest growth through 2029, driven primarily by the expanding PAD population and the availability of new premium-priced products. However, market revenues…

The Asia Pacific market for PV devices will grow modestly through 2029, fueled by the growing PAD population and the adoption of premium devices like DCBs, DES, and powered thrombectomy…

The European market for PV devices is a dynamic market that will grow steadily through 2029, driven by the availability of new products backed by clinical data. However, market revenues will be…

The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product launches will facilitate significant procedure…

A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however,…

The Japanese PV device market will see modest growth through 2028, driven primarily by the expanding PAD population and the availability of new premium-priced products, such as DES and …

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for significant expansion through 2028. This …